P53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release

Journal of Hepatology

Volumn 59, Issue 4, 2013, Pages 762-768

  Yan, He Xin ^a,b   Wu, Hong Ping ^a,b   Zhang, Hui Lu ^a   Ashton, Charles ^b   Tong, Chang ^b   Wu, Han ^a   Qian, Qi Jun ^a   Wang, Hong Yang ^a   Ying, Qi Long ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

HCC; HMGB1; Inflammation; p53

Indexed keywords

CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; LIVER PROTECTIVE AGENT; PROTEIN P53; PYRUVIC ACID ETHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; GENE TRANSLOCATION; HEPATITIS; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIVER CARCINOGENESIS; LIVER CELL; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; STELLATE CELL; SUPERNATANT; WILD TYPE;

DEN; DIETHYLNITROSAMINE; HCC; HEPATOCELLULAR CARCINOMA; HIGH-MOBILITY GROUP PROTEIN 1; HMGB1; INFLAMMATION; P53;

ANIMALS; CELL LINE; DIETHYLNITROSAMINE; GENE KNOCKOUT TECHNIQUES; GENES, P53; HEPATITIS, CHRONIC; HMGB1 PROTEIN; INFLAMMATION; INFLAMMATION MEDIATORS; LIVER NEOPLASMS, EXPERIMENTAL; RATS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884413371     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.05.029     Document Type: Article

References (40)

1. S.S. Hecht Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention Lancet Oncol 3 2002 461 469 (Pubitemid 34863666)
2. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917 (Pubitemid 37518510)
3. N. Uemura, S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi, and M. Yamakido Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 2001 784 789
4. A. Kuraishy, M. Karin, and S.I. Grivennikov Tumor promotion via injury- and death-induced inflammation Immunity 35 2011 467 477
5. A. Efeyan, and M. Serrano P53: guardian of the genome and policeman of the oncogenes Cell Cycle 6 2007 1006 1010 (Pubitemid 46708570)
6. K.H. Vousden, and C. Prives Blinded by the light: the growing complexity of p53 Cell 137 2009 413 431
7. H.X. Yan, H.P. Wu, C. Ashton, C. Tong, and Q.L. Ying Rats deficient for p53 are susceptible to spontaneous and carcinogen-induced tumorigenesis Carcinogenesis 33 2012 2001 2005
8. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195 (Pubitemid 34773774)
9. A. Tsung, R. Sahai, H. Tanaka, A. Nakao, M.P. Fink, and M.T. Lotze The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion J Exp Med 201 2005 1135 1143 (Pubitemid 40524681)
10. C. Tong, P. Li, N.L. Wu, Y. Yan, and Q.L. Ying Production of p53 gene knockout rats by homologous recombination in embryonic stem cells Nature 467 2010 211 213
11. M.F. Rajewsky, W. Dauber, and H. Frankenberg Liver carcinogenesis by diethylnitrosamine in the rat Science 152 1966 83 85
12. L.X. Yu, H.X. Yan, Q. Liu, W. Yang, H.P. Wu, and W. Dong Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents Hepatology 52 2010 1322 1333
13. T. Mello, A. Nakatsuka, S. Fears, W. Davis, H. Tsukamoto, and W.F. Bosron Expression of carboxylesterase and lipase genes in rat liver cell-types Biochem Biophys Res Commun 374 2008 460 464
14. H.X. Yan, H.P. Wu, H.L. Zhang, C. Ashton, C. Tong, and J. Wu DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats Oncogene 2012 10.1038/onc.2012.451
15. S.K. Biswas, A. Sica, and C.E. Lewis Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms J Immunol 180 2008 2011 2017
16. R.A. Roberts, P.E. Ganey, C. Ju, L.M. Kamendulis, I. Rusyn, and J.E. Klaunig Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis Toxicol Sci 96 2007 2 15 (Pubitemid 46323203)
17. L.A. Banaszynski, L.C. Chen, L.A. Maynard-Smith, A.G. Ooi, and T.J. Wandless A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules Cell 126 2006 995 1004 (Pubitemid 44310772)
18. A. Freund, A.V. Orjalo, P.Y. Desprez, and J. Campisi Inflammatory networks during cellular senescence: causes and consequences Trends Mol Med 16 2010 238 246
19. F. Rodier, J.P. Coppe, C.K. Patil, W.A. Hoeijmakers, D.P. Munoz, and S.R. Raza Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion Nat Cell Biol 11 2009 973 979
20. A. Tsung, J.R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, and X. Peng HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling J Exp Med 204 2007 2913 2923 (Pubitemid 350179560)
21. L. Ulloa, M. Ochani, H. Yang, M. Tanovic, D. Halperin, and R. Yang Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Proc Natl Acad Sci U S A 99 2002 12351 12356
22. H. Yang, H.S. Hreggvidsdottir, K. Palmblad, H. Wang, M. Ochani, and J. Li A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release Proc Natl Acad Sci U S A 107 2010 11942 11947
23. R.R. Zhou, S.S. Zhao, M.X. Zou, P. Zhang, B.X. Zhang, and X.H. Dai HMGB1 cytoplasmic translocation in patients with acute liver failure BMC Gastroenterol 11 2011 21
24. W. Xue, L. Zender, C. Miething, R.A. Dickins, E. Hernando, and V. Krizhanovsky Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Nature 445 2007 656 660 (Pubitemid 46232886)
25. T. Kodama, T. Takehara, H. Hikita, S. Shimizu, M. Shigekawa, and H. Tsunematsu Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice J Clin Invest 121 2011 3343 3356
26. H. Yang, T.W. Li, K.S. Ko, M. Xia, and S.C. Lu Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes Hepatology 49 2009 860 870
27. R.E. Castro, J.D. Amaral, S. Sola, B.T. Kren, C.J. Steer, and C.M. Rodrigues Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes Am J Physiol Gastrointest Liver Physiol 293 2007 G327 G334
28. H. Yang, and K.J. Tracey Targeting HMGB1 in inflammation Biochim Biophys Acta 1799 2010 149 156
29. D.H. Dapito, A. Mencin, G.Y. Gwak, J.P. Pradere, M.K. Jang, and I. Mederacke Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4 Cancer Cell 21 2012 504 516
30. H.L. Zhang, L.X. Yu, W. Yang, L. Tang, Y. Lin, and H. Wu Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats J Hepatol 57 2012 803 812
31. Y. Arase, K. Ikeda, N. Murashima, K. Chayama, A. Tsubota, and I. Koida The long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1997 1494 1500 (Pubitemid 27154778)
32. K. Ikeda, Y. Arase, M. Kobayashi, S. Saitoh, T. Someya, and T. Hosaka A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients Dig Dis Sci 51 2006 603 609
33. G. Shiota, K. Harada, M. Ishida, Y. Tomie, M. Okubo, and S. Katayama Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine- treated mice Carcinogenesis 20 1999 59 63 (Pubitemid 29033845)
34. X.Y. Wan, M. Luo, X.D. Li, and P. He Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine Chem Biol Interact 181 2009 15 19
35. L. Mollica, M.F. De, A. Spitaleri, C. Dallacosta, D. Pennacchini, and M. Zamai Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities Chem Biol 14 2007 431 441 (Pubitemid 46617319)
36. G.S. Feng Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox Cancer Cell 21 2012 150 154
37. P.A. Nikitin, and M.A. Luftig The DNA damage response in viral-induced cellular transformation Br J Cancer 106 2012 429 435
38. H.E. van Gijssel, C.B. Maassen, G.J. Mulder, and J.H. Meerman P53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotion Carcinogenesis 18 1997 1027 1033 (Pubitemid 28132350)
39. D.M. Feldser, K.K. Kostova, M.M. Winslow, S.E. Taylor, C. Cashman, and C.A. Whittaker Stage-specific sensitivity to p53 restoration during lung cancer progression Nature 468 2010 572 575
40. M.R. Junttila, A.N. Karnezis, D. Garcia, F. Madriles, R.M. Kortlever, and F. Rostker Selective activation of p53-mediated tumour suppression in high-grade tumours Nature 468 2010 567 571